Equity Overview
Price & Market Data
Price: $4.39
Daily Change: +$0.10 / 2.28%
Daily Range: $4.15 - $4.49
Market Cap: $60,026,948
Daily Volume: 24,362
Performance Metrics
1 Week: 5.43%
1 Month: 28.38%
3 Months: 57.01%
6 Months: 54.79%
1 Year: 42.18%
YTD: 50.52%
Company Details
Employees: 45
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.